Glial Fibrillary Acidic Protein (GFAP) (pSer38) Peptide
-
- Target See all GFAP products
- GFAP (Glial Fibrillary Acidic Protein (GFAP))
- Protein Region
- pSer38
- Origin
- Human, Mouse, Cow
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Characteristics
- The peptide is used to block Anti-GFAP (pS38) Antibody reactivity.
-
-
- Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
- Expiry Date
- 12 months
-
- Target
- GFAP (Glial Fibrillary Acidic Protein (GFAP))
- Synonyms
- GFAP Peptide, AI836096 Peptide, cb345 Peptide, etID36982.3 Peptide, gfapl Peptide, wu:fb34h11 Peptide, wu:fk42c12 Peptide, xx:af506734 Peptide, zgc:110485 Peptide, glial fibrillary acidic protein Peptide, GFAP Peptide, LOC100136168 Peptide, gfap Peptide, Gfap Peptide
- Background
- Glial fibrillary acidic protein, GFAP
- Gene ID
- 2670, 14580
- UniProt
- P14136, P03995
-